2dg9: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2dg9.gif|left|200px]] | [[Image:2dg9.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2dg9", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
| | --> | ||
| | {{STRUCTURE_2dg9| PDB=2dg9 | SCENE= }} | ||
}} | |||
'''FK506-binding protein mutant WL59 complexed with Rapamycin''' | '''FK506-binding protein mutant WL59 complexed with Rapamycin''' | ||
| Line 29: | Line 26: | ||
[[Category: Fulton, K F.]] | [[Category: Fulton, K F.]] | ||
[[Category: Jackson, S E.]] | [[Category: Jackson, S E.]] | ||
[[Category: | [[Category: Immunophilin]] | ||
[[Category: | [[Category: Isomerase]] | ||
[[Category: | [[Category: Rotamase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 00:21:45 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
Revision as of 00:21, 4 May 2008
FK506-binding protein mutant WL59 complexed with Rapamycin
OverviewOverview
Tryptophan 59 forms the seat of the hydrophobic ligand-binding site in the small immunophilin FKBP12. Mutating this residue to phenylalanine or leucine stabilizes the protein by 2.72 and 2.35 kcal mol(-1), respectively. Here we report the stability data and 1.7 A resolution crystal structures of both mutant proteins, complexed with the immunosuppressant rapamycin. Both structures show a relatively large response to mutation involving a helical bulge at the mutation site and the loss of a hydrogen bond that anchors a nearby loop. The increased stability of the mutants is probably due to a combination of improved packing and an entropic gain at the mutation site. The structures are almost identical to that of wild-type FKBP12.6, an isoform of FKBP12 that differs by 18 residues, including Trp59, in its sequence. Therefore, the structural difference between the two isoforms can be attributed almost entirely to the identity of residue 59. It is likely that in FKBP12-ligand complexes Trp59 provides added binding energy at the active site at the expense of protein stability, a characteristic common to other proteins. FKBP12 associates with the ryanodine receptor in skeletal muscle (RyR1), while FKBP12.6 selectively binds the ryanodine receptor in cardiac muscle (RyR2). The structural response to mutation suggests that residue 59 contributes to the specificity of binding between FKBP12 isoforms and ryanodine receptors.
About this StructureAbout this Structure
2DG9 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Energetic and structural analysis of the role of tryptophan 59 in FKBP12., Fulton KF, Jackson SE, Buckle AM, Biochemistry. 2003 Mar 4;42(8):2364-72. PMID:12600203 Page seeded by OCA on Sun May 4 00:21:45 2008